Clinical Trials · NCT04189848

Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc

Name: Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 4Semaglutide Dulaglutide

Phase: Phase 4
Recruitment status: Completed
Sponsor: Novo Nordisk A/S
Enrollment: 104
Start date: Dec 2019
Locations: 1 site, Netherlands
Primary endpoint: Intensity of Injection Site Pain

View Semaglutide compound reference